1Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene,Survivin, expressed in cancer and lymphoma [J]. Nature Med,1997,3(8):917.
2Takahashi R ,Deveraux Q,Tamm I ,et al. A single BIR domain of XIAP sufficient for inhibiting caspases[J]. J Biol Chem, 1998,273(14) : 7787.
3Muchmore SW,Chen J ,Jakob C,et al. Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein Surviving[J]. Mol Cell, 2000,6(1) : 173.
4Li F,Ambrosini G,Chu EY,et al. Control of apoptosis and mitotic spindle checkpoint by Surviving [J]. Nature, 1998,396(6711) :580.
5Skoufias DA,Mollinari C, Lacroix FB, et al. Human Survivin is a kinetochore-associated passenger protein [ J ]. J Cell Biol, 2000,15(7) : 1575.
6Suzuki A, Hayashida M, Ito T, et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4a and Cdk2/Cyclin E complex activation [J]. Oncogene, 2000,19(29) :3225.
7Tamm I,Wang Y,Sausville E,et al. IAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas (CD95),Bax,caspases, and anticancer drugs [J]. Cancer Res, 1998, 58(23) :5315.
8Suzuki A, Ito T, Kawano H,et al. Survivin initiates procaspase-3/p21 complex formation as a result of interaction with cdk4 to resist Fas-mediated cell death[J]. Oncogene ,2000,19(10) : 1346.
9Mesri M, Morales-Ruiz M, Ackermann E J et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by Survivin targeting [J]. Am J Pathol, 2001, 158(5) :1757.
10Papapetropoulos A, Fulton D, Makboubik, et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/Survivin pathway[J].J Biol Chem,2000,275(13) :9102.
5Hazar B,Ergin M,Seyrek E,et al.Cyclooxygenase-2(Cox-2) expression in lymphomas[J].Leuk Lymphoma,2004,45(7):1395.
6Colette A,Corinne H,Philippe G,et al.Prognostic significance of survivin expression in diffuse large B-cell lymphomas[J].Blood,2000,96(5):1921.
7Isaacson PG.The current status of lymphoma classification[J].Br J Haematol,2000,109(2):258.
8Khuri FR,Wu H,Lee JJ,et al.Cycloxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer[J].Clin Cancer Res,2001,7(4):861.
